- Company search
- VOLUTION IMMUNO PHARMACEUTICALS (UK) LTD
VOLUTION IMMUNO PHARMACEUTICALS (UK) LTD
Company is dissolved
General Information
NAME
VOLUTION IMMUNO PHARMACEUTICALS (UK) LTD
COMPANY NUMBER
09187495
COMPANY TYPE
Private limited with Share Capital
BUSINESS ACTIVITY (SIC)
72110 -
Research and experimental development on biotechnology
INCORPORATION DATE
22/08/2014
(10 years and 2 months old)
WEBSITE
N/A
CONFIRMATION STATEMENT MADE UP TO
22/08/2015
ACCOUNTS MADE UP TO
N/A
KEEP INFORMED
You are not receiving notifications about this company.
PREVIOUS NAMES
26/09/2014
02/10/2014
VOLUTION IMMUNO PHARMACEUTICAL (UK) LTD
View all previous names
Previous Names
26/09/2014 02/10/2014 VOLUTION IMMUNO PHARMACEUTICAL (UK) LTD
22/08/2014 26/09/2014 VOLUTION IMMUNO LTD
WEST MIDLANDS
CV3 4GA
5-6 Argosy Court
Scimitar Way
Coventry
West Midlands
CV3 4GA
Credit Risk Overview
Want to learn more about VOLUTION IMMUNO PHARMACEUTICALS (UK) LTD?
Purchase the company report or an
Annual Subscription
to view this information.
CREDIT RISK
N/APurchase to view all Since 01/01/1970 |
CREDIT LIMIT
£0 GBPSince 01/01/1970 |
COUNTY COURT JUDGEMENTS
1In Judgement £0Total Requested 1Satisfied £0Total paid |
Documents
Date Filed | Description | Download | Group |
---|---|---|---|
Company does not have any documents. |
Group Structure Overview
Company Name | Status | Report |
---|---|---|
This company does not have a group structure. |
Timeline Overview
Date | Event |
---|---|
Date: 24/07/2024 | Event: New Board Member David Anthony Byrne (903911139) Appointed |
Date: 11/07/2024 | Event: New Board Member David Anthony Byrne (903911139) Appointed |
Date: 22/12/2023 | Event: New Board Member David Anthony Byrne (903911139) Appointed |
Credit Risk Overview
Want to learn more about VOLUTION IMMUNO PHARMACEUTICALS (UK) LTD?
Purchase the company report or an
Annual Subscription
to view this information.
CREDIT RISK
N/APurchase to view all Since 01/01/1970 |
CREDIT LIMIT
£0 GBPSince 01/01/1970 |
COUNTY COURT JUDGEMENTS
1In Judgement £0Total Requested 1Satisfied £0Total paid |
Credit Health History
Want to learn more about VOLUTION IMMUNO PHARMACEUTICALS (UK) LTD?
Purchase the company report or an
Annual Subscription
to view this information.
Want to learn more about VOLUTION IMMUNO PHARMACEUTICALS (UK) LTD?
Purchase the company report or an
Annual Subscription
to view this information.
Accounts
Directors & Secretaries
Personal Information | Status | Position | Appointments | Report |
---|---|---|---|---|
Born in Mar 1955 |
Status: Resigned | Position: Director | Appointments:
Current: 1 Past: 61 |
View Report |
Born in N/A |
Status: Resigned | Position: Director | Appointments:
Current: 1 Past: 381 |
View Report |
Born in Nov 1959 |
Status: Resigned | Position: Director | Appointments:
Current: 11 Past: 84 |
View Report |
Documents
Date Filed | Description | Download | Group |
---|---|---|---|
Company does not have any documents. |
Group Structure Overview
Company Name | Status | Report |
---|---|---|
This company does not have a group structure. |
Timeline Overview
Date | Event |
---|---|
Date: 24/07/2024 | Event: New Board Member David Anthony Byrne (903911139) Appointed |
Date: 11/07/2024 | Event: New Board Member David Anthony Byrne (903911139) Appointed |
Date: 22/12/2023 | Event: New Board Member David Anthony Byrne (903911139) Appointed |
Date: 06/07/2023 | Event: New Board Member David Anthony Byrne (903911139) Appointed |
Date: 11/09/2015 | Event: New Annual Return filed |
Date: 19/01/2015 | Event: Change in Reg. Office |
Date: 06/09/2014 | Event: New Board Member Paul Marcus George Voller (916572847) Appointed |
Date: 06/09/2014 | Event: Paul Marcus George Voller (919038654) has left the board |
Free Credit Score Toolkit
Make better business decisions
Get helpful tips on how to use company credit reports when making potentially critical business choices.
- How to find out who’s really behind the business with director and shareholder information
- What a credit score means and the factors that affect your own company’s credit rating
- Which financial figures are key when assessing a potential partner or supplier